FDA Releases Draft Guidances on Medical Product Information and Withdraws Guidance on Patient Labeling

Summary

The Food and Drug Administration (FDA) has released three draft guidances to improve information about medical products and health conditions, while withdrawing a draft guidance on using approved patient labeling in print advertisements. The new guidances focus on risk disclosure, disease awareness, and broadcast advertising of restricted devices.